FDA Investigator Anthony C Warchut

Anthony C Warchut has conducted inspections on 145 sites in 7 countries as of 02 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
145
Last Inspection Date:
02 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100002556
Countries of Inspections:
Italy, United States of America, Germany, United Kingdom of Great Britain and Northern Ireland, France, Canada, Austria
FDA Investigators that have inspected at least one site in common with Anthony C Warchut:
Abdur Rafay Shareef, Adetutu M Gidado, Alice C Silva, Alicia M Mozzachio, Amber G Wardwell, Amy C Jordan, Anastasia M Shields, Andrew M Barlow, Anissa M Cheung, Anna Lazar, Anna M Brannen, Anthony A Charity, Anthony N Onianwa, Arie C Menachem, Arthur T Ogdahl, Azza Talaat, Brandy N Lepage, Brenda P King, Brenna L Macdowell, Brentley S Collins, Brian D Nicholson, Bryan L Mcguckin, Burnell M Henry, Byungja E Marciante, Carl A Huffman, III, Cassandra L Abellard, CDR Jeremy L Wally, PhD, Charles M Edwards, Charles R Cote, RIC, Christian F Gomez Lugo, Christina Capacci Daniel, PhD, Christine M Whitby, CSO, Christopher Janik, Chunsheng Cai, PhD, Constance Desimone, Courtney N Long, Cynthia A Palmer, Cynthia F Kleppinger, MD, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Deborah A Greco, Deborah M Trout, Demitria J Xiradakis, Diane C Thibodeau, Diane M Prince, Dien N Nguyen, Dina K West, Doan T Nguyen, PharmD, Dominic R Frasca, Donald C Obenhuber, PhD, Donald L Lech, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Ekaterina Allen, Elizabeth Ll Edwards, Ellen P Madigan, Emily J Orban, Emily J Schramm, Eric M Mueller, PharmD, Erika V Butler, Erin D Mccaffery, Erin I Keith, Evan Tong, Frederick F Razzaghi, Gabrielle J Swain, Gale E Ryan, Gam S Zamil, Gary J Hagan, George J Flynn, Geraldine D Sanders, Gerard D Difiore, Hang N Guo, Heika R Tait, Helen B Ricalde, Holly Brevig, James C Maclaughlin, Janete F Guardia, Javier O Vega, Jawaid Hamid, Jayaleka J Amarasinghe, Jeffrey A Sommers, Jeffrey J Thibodeau, John A Hollings, John J Thibodeau, John P Mistler, Jonah S Ufferfilge, Jonathan G Matrisciano, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Jose R Hernandez, Junho Pak, Justin A Boyd, Justine M Corson, Justine Tomasso, Katherine D Adams, Katherine Szestypalow, Katie L Korchinski, Kelly R Lewis, Kenneth H Williams, Kent A Conforti, Kham Phommachanh, Kimberly M White, Larry K Austin, Laura L Staples, Laurie A Haxel, Laurie B Frazier, LCDR Debra Emerson, Libia M Lugo, Linda L Green, Lirissia Mccoy, Lori A Holmquist, LT Tamara J Henderson, Luis A Dasta, Lynda L Perry, PhD, Margaret A Smithers, Margaret E Walsh, Margaret M Annes, Margaret M Sands, Marianela Aponte Cruz, Marie A Fadden, Marie F Morin, Mark A Heard, Mark C Lookabaugh, Mark R Mcclain, Martin J Guardia, Marvin D Jones, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maya M Davis, Megan A Haggerty, Mei Chiung Huang (Jo), Meisha A Mandal, Melinda L Rice, Miah Jung, Michael F Skelly, PhD, Michael G Mayfield, Michael J Sevka, MD, Michael L Chasey, Michael S Araneta, Michele L Obert, Michelle M Noe Varga, Miguel A Martinez Perez, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Nabil Nakhoul, Nadeem I Chaudhry, Nealie C Newberger, Nebil A Oumer, Nicole E Knowlton, Nina Yang, Omotunde O Osunsanmi, Paige R Mccoy, Paraluman S Leonin, Parul M Patel, Paul E Stein, Paul L Bellamy, Peter R Lenahan, Phillip E Mclaughlin, Raeann R Wu, Rajiv R Srivastava, Ramon E Martinez, Rapti D Madurawe, Reba A Gates, Rebecca B Welch, Rebecca E Dombrowski, Rebecca Parrilla, Robert J Martin, Robin Levis, PhD, Rory K Geyer, Rose Ashley, Rose Xu, Rozelle G Smith, Russell J Glapion, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Samina S Khan, Samir C Gala, Samuel T Walker, Sandra A Hughes, Sara M Onyango, Satheesh Thomas, Sean R Marcsisin, Sharon K Gershon, Sharon K Thoma, PharmD, Shirley J Berryman, Simone E Pitts, Sneha S Patel, Sony Mathews, Stacey S Degarmo, Stacie A Woods, Stephanie A Slater, MS, Stephanie Mangigian, MS/OSH, RN, Stephen R Souza, Sunita Pandey, Susan M Jackson, Susanna E Ford, Susanne M Richardson, MS RAC, Suzanne M Healy, Tamil Arasu, PhD, Tanya R Syffrard, Todd D Alspach, Tonya R Johnson, Torrance J Slayton, Towanda L Terrell, Truong Xuan Nguyen (Andy), Valentino Fiorella, Victoria M Daddeo, Wayne T Smith, Xiaokuang Lai, PhD, Yumi J Hiramine, Yvins Dezan, Zachary L Stamm, Zakaria I Ganiyu, Zhongren Wu

Anthony C Warchut's Documents

Publish Date Document Type Title
May, 2002 EIR Selwyn A. Cohen, M.D., Clinical Investigator - EIR, 2002-05-09
January, 2000 EIR Michael Spiegel, MD - EIR, 2000-01-14
August, 2002 EIR Ecometics, Inc. - EIR, 2002-08-08
December, 2003 FDA 483 R.S.A. Corp. - Form 483, 2003-12-10
May, 2000 EIR Jeffrey Breiter, Md - EIR, 2000-05-17
March, 2004 EIR SICOR Societa' Italiana Corticosteroidi s.r.l. - EIR, 2004-04-14
August, 2000 FDA 483 Pfizer Global Research & Development, Pfizer Inc. - Form 483, 2000-08-10
March, 2004 EIR Chemi SpA - EIR, 2004-05-04
February, 2003 FDA 483 Corden Pharma Bergamo SpA - Form 483, 2003-02-14
February, 2003 FDA 483 TEVA PHARMACEUTICAL FINE CHEMICALS SRL. - Form 483, 2003-02-24
January, 2001 EIR Purdue Pharma L.P. - EIR, 2001-01-02
April, 2000 EIR Fine Organics Limited - EIR, 2000-04-04
May, 2000 FDA 483 Bayer HealthCare Pharmaceuticals Inc - Form 483, 2000-05-04
March, 2002 EIR Patheon Austria GmbH & CoKG - EIR, 2002-05-02
December, 2003 FDA 483 Response R.S.A. Corp. - Form 483R, 2004-01-05
May, 2006 FDA 483 Curia Massachusetts, Inc. - Form 483, 2006-05-24
January, 2001 FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483, 2001-01-16
February, 2003 EIR SICOR Societa' Italiana Corticosteroidi s.r.l. - EIR, 2003-03-19
March, 2002 FDA 483 Response Patheon Austria GmbH & CoKG - Form 483R, 2002-05-31
July, 2001 EIR Lincare Inc. - EIR, 2001-07-03
December, 2001 EIR Purdue Pharma, L.P. - EIR, 2001-12-18
February, 2003 FDA 483 Response SICOR Societa' Italiana Corticosteroidi s.r.l. - Form 483R, 2003-04-03
December, 2003 EIR R.S.A. Corp. - EIR, 2003-12-10
May, 2000 FDA 483 Jeffrey Breiter, Md - Form 483, 2000-05-17
July, 2001 EIR Bayer HealthCare Pharmaceuticals Inc - EIR, 2001-07-23
October, 2002 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2002-10-03
October, 2005 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2005-10-19
February, 2004 EIR Pfizer Inc. Groton Laboratories - EIR, 2004-02-04
January, 2005 FDA 483 Charles River Laboratories Preclinical Services - Form 483, 2005-01-27
August, 2001 EIR Paul R. Solomon, Ph.D. - EIR, 2001-08-03
January, 2001 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2001-01-16
February, 2003 EIR Corden Pharma Bergamo SpA - EIR, 2003-05-16
January, 2005 EIR Charles River Laboratories Preclinical Services - EIR, 2005-01-27
August, 2000 EIR Pfizer Global Research & Development, Pfizer Inc. - EIR, 2000-08-10
February, 2003 EIR Trifarma, S.p.A. - EIR, 2003-02-27
February, 2005 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2005-02-24
March, 2001 FDA 483 Intervet Production S.A. - Form 483, 2001-03-15
March, 2002 FDA 483 Response AbbVie Deutschland GmbH & Co KG - Form 483R, 2002-04-02
February, 2003 FDA 483 Industria Chimica Milanese - Form 483, 2003-02-27
August, 2002 FDA 483 Ecometics, Inc. - Form 483, 2002-08-08
April, 2000 FDA 483 FINE ORGANICS, DIV. LAPORTE FINE CHEMICAL - Form 483, 2000-04-04
April, 2000 FDA 483 Response Fine Organics Limited - Form 483R, 2000-05-02
January, 2003 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2003-01-23
May, 2003 EIR Pfizer Inc. Groton Laboratories - EIR, 2003-05-01
March, 2002 EIR AbbVie Deutschland GmbH & Co KG - EIR, 2002-03-14
February, 2001 EIR Pfizer Inc. Groton Laboratories - EIR, 2001-02-28
November, 2001 EIR Pfizer Inc. Groton Laboratories - EIR, 2001-11-29
June, 2003 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2003-06-09
March, 2002 FDA 483 Abbot Gmbh & Co. KG - Form 483, 2002-03-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more